Filing Details

Accession Number:
0001179110-16-029281
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-09-02 17:25:50
Reporting Period:
2016-08-31
Filing Date:
2016-09-02
Accepted Time:
2016-09-02 17:25:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1113481 Medicines Co MDCO Pharmaceutical Preparations (2834) 043324394
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1204787 Clive Meanwell 8 Sylvan Way
Parsippany NJ 07054
Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-08-31 378 $28.08 339,168 No 4 A Direct
Common Stock Acquisiton 2016-09-01 1,377 $28.60 340,545 No 4 M Direct
Common Stock Disposition 2016-09-01 1,377 $40.00 339,168 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right-to-buy) Disposition 2016-09-01 1,377 $0.00 1,377 $28.60
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
68,623 2017-02-16 No 4 M Direct
Footnotes
  1. Acquired pursuant to The Medicines Company Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period beginning March 1, 2016 and ending August 31, 2016. In accordance with the terms of the ESPP, these shares were purchased based on 85% of the fair market value closing price of the issuer's common stock on March 1, 2016.
  2. Sales were effected pursuant to a Rule 10b-5 program adopted by Dr. Meanwell.
  3. This option vested in forty-eight equal installments beginning on March 16, 2007.
  4. Not applicable.